Core Viewpoint - Shenzhen Oat Technology Co., Ltd. has announced adjustments to the grant prices of its restricted stock incentive plans for 2022 and 2023, reducing the grant price from 9.02 CNY to 8.53 CNY for 2022 and from 5.61 CNY to 5.12 CNY for 2023 [1][10]. Group 1: Adjustment Details - The grant price for the 2022 restricted stock incentive plan has been adjusted from 9.02 CNY per share to 8.53 CNY per share [1][10]. - The grant price for the 2023 restricted stock incentive plan has been adjusted from 5.61 CNY per share to 5.12 CNY per share [1][10]. - The adjustments were made in accordance with the company's incentive plan regulations, considering factors such as capital increases and dividend distributions [9][10]. Group 2: Decision-Making Process - The board of directors and the supervisory board have reviewed and approved the adjustments, ensuring compliance with relevant laws and regulations [1][10]. - Independent directors provided opinions affirming that the adjustments are beneficial for the company's sustainable development and do not harm the interests of shareholders [1][10]. - The supervisory board has verified the eligibility of the incentive recipients and the conditions for granting the stock [8][10]. Group 3: Impact and Legal Opinions - The adjustments to the grant prices are not expected to have a substantial impact on the company's financial status and operational results [10]. - Legal opinions confirm that the adjustments and related matters have received the necessary approvals and comply with applicable laws and regulations [11].

Core Points - The company has reviewed and approved the list of 27 incentive recipients for the 2023 restricted stock incentive plan, confirming their eligibility under relevant laws and regulations [1][2] - A total of 235,762 shares of restricted stock will be granted to the approved recipients, which aligns with legal and regulatory requirements and does not harm the interests of the company and its shareholders [2] Summary by Sections - **Eligibility and Compliance** - The 27 incentive recipients meet the qualifications set forth by the Company Law, Securities Law, and other relevant regulations, confirming their legal and effective status as recipients of the incentive plan [1] - **Stock Allocation** - The total number of restricted shares to be granted is 235,762, which complies with all applicable laws and regulations [2]

| 深圳市他山企业管理咨询有限公司 | | | --- | --- | | 关于深圳市燕麦科技股份有限公司 | | | 预留授予部分第一个归属期符合归属条件事项的 | | | 独立财务顾问报告 | | | 二〇二五年八月 | | | 目 录 | | | 深圳市他山企业管理咨询有限公司 | 独立财务顾问报告 | | 释 义 | | | 除非上下文文意另有所指，下列词语具有如下含义： | | | 燕麦科技、公司 指 | 深圳市燕麦科技股份有限公司 | | 深圳市燕麦科技股份有限公司 | 2023 年限制性股票激励 | | 本激励计划 指 | | | 计划 | | | 《深圳市燕麦科技股份有限公司 | 2023 年限制性股票激 | | 《股权激励计划（草案）》 指 | | | 励计划（草案）》 | | | 《深圳市他山企业管理咨询有限公司关于深圳市燕麦 | | | 科技股份有限公司 2023 | 年限制性股票激励计划调整事 | | 独立财务顾问报告、本报告 指 | | | 项及预留授予部分第一个归属期符合归属条件事项的 | | | 独立财务顾问报告》 | | | 限制性股票、第二类限制性 | 满足归属条件后，按本激 ...

Core Viewpoint - Shenzhen Oat Technology Co., Ltd. has announced the first vesting period of its 2023 restricted stock incentive plan, confirming that the conditions for vesting have been met for a total of 23.5762 million shares [1][12][18] Summary by Sections Incentive Plan Overview - The total number of restricted stocks granted is 3.021524 million shares, with 2.55 million shares for the first grant (84.39%) and 471524 shares reserved (15.12%) [1] - The purchase price for the restricted stocks is set at 5.12 yuan per share [1][11] Vesting Arrangement - The first vesting period for the initial grant is from the first trading day after 16 months to the last trading day within 28 months [2] - The second vesting period for the initial grant is from the first trading day after 28 months to the last trading day within 40 months [2] - The first vesting period for the reserved grant is from the first trading day after 12 months to the last trading day within 24 months [2] - The second vesting period for the reserved grant is from the first trading day after 24 months to the last trading day within 36 months [2] Performance Assessment - The performance assessment for the first vesting period requires a revenue growth rate of no less than 10% for 2024 based on 2023 revenue [3][5] - Alternatively, a net profit growth rate of no less than 15% for 2024 based on 2023 net profit is also acceptable [3] - The performance assessment for the second vesting period requires a revenue growth rate of no less than 20% for 2025 based on 2023 revenue [5] - Alternatively, a net profit growth rate of no less than 30% for 2025 based on 2023 net profit is also acceptable [5] Compliance and Approval - The board of directors and the supervisory board have approved the incentive plan and confirmed that the vesting conditions have been met for the reserved grant [12][18] - A total of 27 individuals are eligible for the reserved grant, with the vesting conditions confirmed [12][18] Financial Reporting and Accounting - The company will account for the stock-based compensation in accordance with relevant accounting standards, using the Black-Scholes model to determine the fair value of the restricted stocks [17] - The company will adjust the expected number of vested shares based on changes in eligible individuals and the completion of vesting conditions [17]

证券代码：688426 证券简称：康为世纪 公告编号：2025-030 事会第十四次会议审议，通过了《关于 2024 年限制性股票激励计划第一个归属 期不符合归属条件暨作废已授予尚未归属的限制性股票的议案》，同意对 2024 年限制性股票激励计划中已获授但尚未归属的第二类限制性股票 2,098,400 股全 部取消归属，并作废失效。 江苏康为世纪生物科技股份有限公司 关于 2024 年限制性股票激励计划第一个归属期不符合 归属条件暨作废已授予尚未归属的限制性股票的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏康为世纪生物科技股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开的第二届董事会第十六次会议和第二届监事会第十四次会议审议通过了 《关于 2024 年限制性股票激励计划第一个归属期不符合归属条件暨作废已授予 尚未归属的限制性股票的议案》，同意对 2024 年限制性股票激励计划中已获授但 尚未归属的第二类限制性股票 2,098,400 股全部取消归属，并作废失效。其中 失去了激励资格须予以作 ...

Meeting Overview - The second board meeting of Beijing Innotech Biotechnology Co., Ltd. was held on August 27, 2025, with all 9 directors present, and the meeting complied with relevant laws and regulations [1]. Financial Reports - The board approved the 2025 semi-annual report and its summary with a unanimous vote of 9 in favor [2]. - The board also approved a special report on the storage and actual use of raised funds for the first half of 2025, confirming compliance with regulations and proper use of funds [2]. Cash Management - The board agreed to use up to RMB 300 million of idle raised funds for cash management, allowing for the purchase of safe and liquid financial products, with a rolling usage period from September 2, 2025, to September 1, 2026 [3]. - Additionally, the board approved the use of up to RMB 1.7 billion of idle self-owned funds for similar cash management purposes during the same period [4]. Stock Incentive Plan - The board approved an adjustment to the grant price of the 2023 restricted stock incentive plan from RMB 13.20 per share to RMB 12.65 per share [5]. - A semi-annual evaluation report on the "Quality Improvement and Efficiency Enhancement" action plan for 2025 was also approved [6]. Corporate Governance Changes - The board approved changes to the registered capital and the cancellation of the supervisory board, allowing the audit committee to assume its responsibilities [7]. - The board agreed to revise and add certain company regulations to enhance governance structure [8]. Fund Allocation - The board approved the use of RMB 60 million of surplus raised funds for the "In Vitro Diagnostic Product R&D Project" and extended the project's timeline by 18 months [10]. Stock Incentive Plan Draft - The board approved the draft of the 2025 restricted stock incentive plan, which aims to attract and retain talent while aligning interests among shareholders, the company, and core team members [11][13]. Authorization for Stock Incentive Plan - The board proposed to seek shareholder authorization for handling matters related to the 2025 restricted stock incentive plan [15]. Insurance for Directors - A proposal for purchasing liability insurance for directors and supervisors was submitted for shareholder approval due to the absence of a valid resolution [17]. Shareholder Meeting - The board approved a proposal to convene the first extraordinary general meeting of shareholders in 2025 [14].

Core Viewpoint - The legal opinion letter from Gao Peng Law Firm confirms that Shandong Huifa Food Co., Ltd. has not met the conditions for the first unlock period of its 2024 restricted stock incentive plan, leading to the repurchase and cancellation of certain restricted stocks [1][6]. Group 1: Approval and Authorization - The company has obtained necessary approvals and authorizations for the repurchase and cancellation of restricted stocks as per the resolutions passed in the shareholders' meeting [6][7]. - The board of directors has been authorized to handle matters related to the granting, unlocking, and repurchase of restricted stocks [6][7]. Group 2: Repurchase and Cancellation Details - The repurchase is due to the failure to meet performance assessment targets, resulting in the cancellation of 2,261,520 shares of restricted stock [8][9]. - The repurchase price is set at 4.57 yuan per share plus the interest from bank term deposits [9]. - The funds for the repurchase will be sourced entirely from the company's own funds [9]. Group 3: Legal Compliance - The legal opinion asserts that the reasons, quantities, prices, and funding sources for the repurchase comply with relevant laws and regulations, including the Company Law and the Management Measures for Incentive Plans [9]. - The company is required to fulfill its information disclosure obligations and follow legal procedures for capital reduction and share cancellation [9].

Group 1 - The company has approved the 2025 Restricted Stock Incentive Plan and the list of initial grant recipients during the board and supervisory meetings held on August 18, 2025 [1] - The company publicly disclosed the incentive plan and the list of recipients on its internal bulletin board and through the official website, with a public notice period from August 19 to August 28, 2025 [1][2] - The supervisory board conducted a verification of the proposed recipients, ensuring they meet the qualifications set forth in relevant laws and regulations, as well as the company's articles of association [2][3] Group 2 - The supervisory board confirmed that the proposed recipients do not include any individuals disqualified under the relevant laws, such as those recognized as inappropriate candidates by the stock exchange or the China Securities Regulatory Commission [2][3] - The verification process included checking the recipients' identities, employment contracts, and positions within the company [2] - The supervisory board received no objections regarding the proposed list of recipients during the public notice period [1][2]

Summary of Key Points Core Viewpoint - The company, Shanghai Huidet Technology Co., Ltd., announced the repurchase and cancellation of 21,000 restricted stocks due to one incentive plan participant leaving the company, which resulted in their disqualification from the incentive program [1][2]. Group 1: Repurchase and Cancellation Details - The repurchase and cancellation of restricted stocks is based on the company's incentive plan, which stipulates that if an incentive participant leaves, their unvested stocks must be repurchased and canceled [1][2]. - The repurchase price for the restricted stocks has been adjusted from 7.27 yuan per share to 6.90 yuan per share following the completion of the 2024 annual equity distribution [1][2]. - The company has opened a dedicated securities account for the repurchase and expects the cancellation to be completed by September 2, 2025 [2][3]. Group 2: Impact on Share Structure - Following the cancellation, the total share capital of the company will decrease by 21,000 shares, resulting in a new total of 141,132,667 shares [2][3]. - The proportion of unrestricted circulating shares will increase slightly from 98.24% to 98.25%, while the proportion of restricted circulating shares will decrease from 1.76% to 1.75% [2][3]. Group 3: Compliance and Legal Assurance - The board of directors confirmed that the decision-making process and information disclosure regarding the repurchase and cancellation comply with relevant laws and regulations [3]. - The company has assured that all involved parties have been informed and have not raised objections regarding the repurchase and cancellation [3].

证券代码：688676 证券简称：金盘科技 公告编号：2025-066 海南金盘智能科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 海南金盘智能科技股份有限公司（以下简称"公司"）第三届董事会第二十 六次会议于 2025 年 8 月 18 日以电子邮件形式发出了本次会议的召开通知，于 董事 6 名，实到董事 6 名，会议由董事长李志远主持。本次会议的召开符合《中 华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、《海南金盘智能科技股份有限公司章程》（以下 简称"《公司章程》"）、《海南金盘智能科技股份有限公司董事会议事规则》 等有关法律、法规、规范性文件的规定，程序合法。 二、董事会会议审议情况 经与会董事认真审议，审核并通过如下事项： （一）审议通过《关于公司<2025 年半年度报告>及其摘要的议案》 经审核，董事会认为公司 2025 年半年度报告及其摘要编制符合法律、法规、 《公司章程》和公司内部管理制度的各项规定。内容和格式 ...